SAXONY’S BIOTECH INDUSTRY UNITES: PRIVATE SECTOR AND SCIENCE JOIN FORCES TO SET UP BIOSAXONY ALLIANCE
In order to safeguard the continuous development of biotechnology in Saxony, the skills of the region’s biotech players have been brought together within the new biosaxony alliance – a registered association acting on behalf of its members throughout Saxony. Now that a critical mass of established biotech companies has been achieved in the region, the biosaxony alliance sees itself as a business initiative with a strong scientific focus. The aims are to use the resulting synergy to support the alliance’s work in thematic focus groups and to show a united front.
The project has been given the full backing of Sabine von Schorlemer, Saxony’s minister of science and the arts. “Under the biosaxony label, Saxony has already made a name for itself in Germany and abroad as a centre of biotechnology and become one of the most dynamic biotech regions anywhere in Europe,” explains Prof von Schorlemer. “I am certain that the work of the newly founded biosaxony alliance will continue to enhance biotech in Saxony.”
This goal is reflected by the biosaxony alliance’s executive committee: Roland Göhde, CEO Partec GmbH (chairman), Dr Wilhelm Zörgiebel, CEO Biotype AG (deputy chairman), Dr André Gerth, CEO BioPlanta GmbH (treasurer), Prof Frank Emmrich, director of the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig, and Prof Kai Lenart Simons, director of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden.